Background: Current lung adenocarcinoma pathological classification, published in 2004 by the
World Health Organisation, has limited clinical utility. A new multidisciplinary classification
has been proposed by the European Respiratory Society, the American Thoracic Society
and the International Association for the Study of Lung Cancer; its validation thus
far is limited. This project investigated the correlation between lung adenocarcinoma
subtype and patient survival.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Heart, Lung and CirculationAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2011 Published by Elsevier Inc.
